跳至主要内容
临床试验/CTRI/2020/01/022712
CTRI/2020/01/022712已完成未知

Comparative Evaluation of Typical Antipsychotic Haloperidol with Atypical Antipsychotics Olanzapine, Risperidone and Aripiprazole in the Treatment of Stable Schizophrenia in a Tertiary Care Teaching Hospital at Dehradun, Uttarakhand

Dr Subhash Vishal0 个研究点目标入组 98 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
98

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Stable schizophrenic with initial BPRS score of >= 24, Clinical Global Impression Severity Rating Scale >= 4

排除标准

  • Age less than 18 or more than 70; pregnant or lactating women, acute emergencies, patients with impaired hepatic or renal function; any systemic illness; history of hypersensitivity / allergy to any of the drugs included in study

研究者

发起方
Dr Subhash Vishal

相似试验